Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772
Read More
Tag: pneumococcal vaccine
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
